PHARMACEUTICAL INDUSTRY
Growing health concerns, increasing consumer interest in preventive care, and the health effectiveness of probiotic microorganisms are among the major factors driving the global market. In both the domestic and global markets there are nutraceuticals, supplements, and medications that include live probiotics or their metabolites in their formulations.
Indeed, probiotics restore the balance of the intestinal microbiota and promote beneficial effects in the prevention and treatment of various pathologies.
The technology involved in the Gabbia coating bioprocess is crucial for preserving the original biological properties of the probiotic microorganisms and allows for high viability of the strains, even in supplements with more demanding pharmaceutical forms.
Microbial cultures with recognized beneficial effects.
- Protection and viability – no physicochemical changes in the product throughout the shelf-life;
- Resistance to variations in temperature, pH and preservatives;
- Stability of the ingredient without the need for refrigeration;
- Standardized concentrations in CFU/g;
- Forms of presentation – Ingredients available in standard and multilayer microencapsulated forms.
Strength – Up to 113 °F / pH – 3.0
Lyophilized – Yes
Purity – 100 Billion CFU / gram
Shelf life – 24 months
DUO Standardization
Resistance – Up to 140 °F / pH – 2.5
Freeze dried – Yes
Coating/micro encapsulation – Double
Purity – 10 Billion CFU / gram
Shelf life – 24 months
Resistance – Up to 212 °F / pH – 2.0
Lyophilized – Yes
Coating/micro encapsulation – Four layers
Purity – 10 Billion CFU / gram
Shelf life – 24 months
Resistance – Up to 302 °F / pH – 1.8
Lyophilized – Yes
Coating/micro encapsulation – Six layers
Purity – 1 Billion CFU / gram
Shelf life – 24 months
How can we help?
For complete information, please contact us.
